Access
To read this story in full you will need to login or make a payment (see right).
Letters to Nature
Nature 418, 99-104 (4 July 2002) | doi:10.1038/nature00862; Received 27 March 2002; Accepted 7 May 2002
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
nature jobs
Medical Writer
- Cactus Global
- Mumbai 400053 India
Faculty Positions in Immunology
- Harvard Medical School (HMS), Dana-Farber Cancer Institute (DFCI)
- Boston, MA
AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification
Svend K. Petersen-Mahrt1, Reuben S. Harris1 & Michael S. Neuberger
- Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK
- These authors contributed equally to this work
Correspondence to: Michael S. Neuberger Correspondence and requests for materials should be addressed to M.S.N. (e-mail: Email: msn@mrc-lmb.cam.ac.uk).
Abstract
After gene rearrangement, immunoglobulin variable genes are diversified by somatic hypermutation or gene conversion, whereas the constant region is altered by class-switch recombination. All three processes depend on activation-induced cytidine deaminase (AID)1, 2, 3, 4, 5, 6, 7, a B-cell-specific protein that has been proposed (because of sequence homology1) to function by RNA editing. But indications that the three gene diversification processes might be initiated by a common type of DNA lesion8, 9, 10, 11, together with the proposal that there is a first phase of hypermutation that targets dC/dG12, suggested to us that AID may function directly at dC/dG pairs. Here we show that expression of AID in Escherichia coli gives a mutator phenotype that yields nucleotide transitions at dC/dG in a context-dependent manner. Mutation triggered by AID is enhanced by a deficiency of uracil-DNA glycosylase, which indicates that AID functions by deaminating dC residues in DNA. We propose that diversification of functional immunoglobulin genes is triggered by AID-mediated deamination of dC residues in the immunoglobulin locus with the outcome—that is, hypermutation phases 1 and 2, gene conversion or switch recombination—dependent on the way in which the initiating dU/dG lesion is resolved.
To read this story in full you will need to login or make a payment (see right).

